Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 15Lung Neoplasms 11Colonic Neoplasms 10Breast Neoplasms 9Brain Neoplasms 7Prostatic Neoplasms 4Emergence Delirium 4Urinary Bladder Neoplasms 3Stomach Neoplasms 3Respiratory Aspiration 3Rectal Neoplasms 3Pituitary Neoplasms 3Neoplastic Cells, Circulating 3Hypoxia 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Agnosia 3Supratentorial Neoplasms 2Postoperative Complications 2Patient Satisfaction 2Pain, Postoperative 2Pain 2Ovarian Neoplasms 2Neoplasm Metastasis 2Melanoma 2Liver Neoplasms 2Leukemia 2Delirium 2Colorectal Neoplasms 2Abdominal Neoplasms 2

Interventions

Levetiracetam 6Cannabidiol 5perampanel 2Tranexamic Acid 2Standard of Care 2Everolimus 2ziprasidone 1enzalutamide 1Zolpidem 1Warfarin 1Vigabatrin 1Vecuronium Bromide 1Vancomycin 1Tobramycin 1Temozolomide 1Spironolactone 1Solutions 1Sodium Chloride 1Sevelamer 1Saline Solution 1Rocuronium 1Remifentanil 1Propofol 1Pregabalin 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Seizures × Propofol × Clear all
NCT05103735 2023-01-31

Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity

Azienda Sanitaria-Universitaria Integrata di Udine

Completed
170 enrolled

Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡